COVID-19: Supplies and Personal Protective Equipment (PPE)
The Department of Health and Human Services announced an agreement with drug maker Gilead Sciences to allow U.S. hospitals to purchase up to 500,000 treatment courses of remdesivir through September, which HHS and state health departments will allocate as they did the previous 120,000 treatment…
The White House Supply Chain Task Force projects the nation will have enough N95 masks to meet pandemic demand for July through October, according to a report released to the Senate Homeland Security and Governmental Affairs Committee for a hearing on federal efforts to procure and distribute…
This document outlines changes made by the Food and Drug Administration to its policy governing the decontamination and reuse of certain respirators during the COVID-19 public health emergency.
Shortages of personal protective equipment (PPE) — much of it sourced from Asia — has taught supply chain leaders some hard lessons during the pandemic. And now, some hospitals and health systems and their supply chain partners are banding together to source more PPE domestically.
Individuals and businesses can make a financial gift to Give a Mask, which donates high-quality, non-medical grade facemasks to hospitals and other community-based organizations through a partnership with the AHA’s 100 Million Mask Challenge.
The AFL-CIO asked the U.S. Court of Appeals for the District of Columbia Circuit to order the Occupational Safety and Health Administration to issue within 30 days an emergency temporary standard to protect U.S. workers from COVID-19 under the Occupational Safety and Health Act of 1970.
The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir.
The Department of Health and Human Services has canceled today's deadline for hospitals and health systems to submit data to inform the agency's distribution of its supply of remdesivir.
The Department of Health and Human Services (HHS) yesterday announced that the next deadline for submitting data to inform the agency’s distribution of its supply of remdesivir is Monday, May 18 at 11:59 p.m. ET.
This week, the AHRMM Learning Community focuses its discussion on the re-emergence of a more typical health care structure. This panel of health care supply chain leaders will share their thoughts and strategies as they prepare supply chain for increased ER visits and elective surgeries. A…